NY S 1351

in committee

Relates to requiring a referenced rate for prescription drugs

New York · 2025-2026 Regular Session · upper

Quick answers

Did NY S 1351 pass?

Not yet. NY S 1351 is in committee as of 2026-01-30 and has not come to a final vote. Latest recorded action (2026-01-30): PRINT NUMBER 1351A

What is NY S 1351 about?

Establishes a pilot program on the referenced rate for prescription drugs; relates to reducing the cost of prescription drugs by establishing maximum wholesale drug prices that are the same as the prices in Canada.

Who sponsors NY S 1351?

Cordell Cleare is the primary sponsor of NY S 1351, joined by 3 cosponsors.

Description

Introduced: —
Latest action: 2026-01-30 — PRINT NUMBER 1351A
Bill type: bill
Last updated: —

Committees

Not provided by source.

Action timeline

2025-01-09
REFERRED TO INSURANCE
referral-committee
2026-01-07
REFERRED TO INSURANCE
referral-committee
2026-01-30
AMEND AND RECOMMIT TO INSURANCE
amendment-passage,referral-committee
2026-01-30
PRINT NUMBER 1351A
amendment-passage

Versions

S1351Compare
S1351ACompare

Documents

Votes

Not provided by source.

Related bills

Prior session: S 8901not in this corpus
Prior session: S 398not in this corpus
Companion bill: A 2126

Official source

https://legislation.nysenate.gov/api/3/bills/2025-2026/S1351?summary=&detail=

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Inspect retained evidence for changes recorded after evidence tracking began:

Source and document changes Status and relationship changes

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 1351. See the API docs or the MCP server for AI assistants.

Known limitations

Sponsor party and chamber affiliation are not yet captured by this API.
Committee referrals are not yet captured.

See the methodology page for data sources and limitations.